杏林製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2012/02/21 | 1,414 | 1,439 | 1,414 | 1,434 | +14 | +1% | 74,000 |
| 2012/02/20 | 1,424 | 1,437 | 1,420 | 1,420 | +5 | +0.4% | 91,000 |
| 2012/02/17 | 1,415 | 1,426 | 1,411 | 1,415 | +5 | +0.4% | 109,000 |
| 2012/02/16 | 1,419 | 1,421 | 1,407 | 1,410 | -6 | -0.4% | 124,000 |
| 2012/02/15 | 1,420 | 1,426 | 1,406 | 1,416 | -4 | -0.3% | 170,000 |
| 2012/02/14 | 1,432 | 1,434 | 1,413 | 1,420 | -12 | -0.8% | 157,000 |
| 2012/02/13 | 1,442 | 1,457 | 1,424 | 1,432 | +6 | +0.4% | 227,000 |
| 2012/02/10 | 1,431 | 1,434 | 1,416 | 1,426 | -5 | -0.3% | 177,000 |
| 2012/02/09 | 1,416 | 1,435 | 1,406 | 1,431 | +1 | +0.1% | 300,000 |
| 2012/02/08 | 1,376 | 1,446 | 1,369 | 1,430 | +66 | +4.8% | 426,000 |
| 2012/02/07 | 1,368 | 1,390 | 1,359 | 1,364 | +8 | +0.6% | 301,000 |
| 2012/02/06 | 1,372 | 1,378 | 1,351 | 1,356 | -15 | -1.1% | 146,000 |
| 2012/02/03 | 1,365 | 1,378 | 1,356 | 1,371 | +6 | +0.4% | 153,000 |
| 2012/02/02 | 1,347 | 1,377 | 1,347 | 1,365 | +18 | +1.3% | 149,000 |
| 2012/02/01 | 1,325 | 1,352 | 1,325 | 1,347 | +22 | +1.7% | 137,000 |
| 2012/01/31 | 1,314 | 1,329 | 1,308 | 1,325 | +11 | +0.8% | 160,000 |
| 2012/01/30 | 1,323 | 1,330 | 1,314 | 1,314 | -8 | -0.6% | 76,000 |
| 2012/01/27 | 1,318 | 1,326 | 1,316 | 1,322 | +4 | +0.3% | 50,000 |
| 2012/01/26 | 1,312 | 1,324 | 1,312 | 1,318 | -2 | -0.2% | 57,000 |
| 2012/01/25 | 1,343 | 1,343 | 1,319 | 1,320 | +5 | +0.4% | 130,000 |
| 2012/01/24 | 1,315 | 1,315 | 1,306 | 1,315 | +1 | +0.1% | 62,000 |
| 2012/01/23 | 1,312 | 1,320 | 1,307 | 1,314 | +3 | +0.2% | 81,000 |
| 2012/01/20 | 1,312 | 1,323 | 1,307 | 1,311 | +9 | +0.7% | 83,000 |
| 2012/01/19 | 1,311 | 1,316 | 1,300 | 1,302 | -8 | -0.6% | 61,000 |
| 2012/01/18 | 1,300 | 1,320 | 1,299 | 1,310 | -7 | -0.5% | 64,000 |
| 2012/01/17 | 1,317 | 1,324 | 1,306 | 1,317 | ±0 | ±0% | 60,000 |
| 2012/01/16 | 1,321 | 1,322 | 1,305 | 1,317 | -6 | -0.5% | 53,000 |
| 2012/01/13 | 1,319 | 1,330 | 1,316 | 1,323 | +5 | +0.4% | 52,000 |
| 2012/01/12 | 1,341 | 1,341 | 1,316 | 1,318 | -29 | -2.2% | 79,000 |
| 2012/01/11 | 1,344 | 1,354 | 1,333 | 1,347 | -6 | -0.4% | 126,000 |
| 2012/01/10 | 1,367 | 1,377 | 1,351 | 1,353 | ±0 | ±0% | 117,000 |
| 2012/01/06 | 1,377 | 1,377 | 1,350 | 1,353 | -14 | -1% | 122,000 |
| 2012/01/05 | 1,377 | 1,382 | 1,339 | 1,367 | -10 | -0.7% | 58,000 |
| 2012/01/04 | 1,375 | 1,387 | 1,372 | 1,377 | +22 | +1.6% | 136,000 |
| 2011/12/30 | 1,345 | 1,364 | 1,337 | 1,355 | +10 | +0.7% | 48,000 |
| 2011/12/29 | 1,335 | 1,355 | 1,318 | 1,345 | +6 | +0.4% | 128,000 |
| 2011/12/28 | 1,344 | 1,344 | 1,317 | 1,339 | -5 | -0.4% | 71,000 |
| 2011/12/27 | 1,351 | 1,351 | 1,340 | 1,344 | +2 | +0.1% | 35,000 |
| 2011/12/26 | 1,344 | 1,350 | 1,337 | 1,342 | -16 | -1.2% | 117,000 |
| 2011/12/22 | 1,368 | 1,372 | 1,354 | 1,358 | -8 | -0.6% | 130,000 |
| 2011/12/21 | 1,359 | 1,366 | 1,348 | 1,366 | +29 | +2.2% | 55,000 |
| 2011/12/20 | 1,341 | 1,343 | 1,331 | 1,337 | -11 | -0.8% | 98,000 |
| 2011/12/19 | 1,358 | 1,358 | 1,334 | 1,348 | +18 | +1.4% | 152,000 |
| 2011/12/16 | 1,326 | 1,349 | 1,324 | 1,330 | +8 | +0.6% | 88,000 |
| 2011/12/15 | 1,314 | 1,327 | 1,314 | 1,322 | -8 | -0.6% | 97,000 |
| 2011/12/14 | 1,322 | 1,335 | 1,321 | 1,330 | -6 | -0.4% | 120,000 |
| 2011/12/13 | 1,346 | 1,351 | 1,334 | 1,336 | -18 | -1.3% | 73,000 |
| 2011/12/12 | 1,351 | 1,358 | 1,347 | 1,354 | +5 | +0.4% | 79,000 |
| 2011/12/09 | 1,354 | 1,354 | 1,338 | 1,349 | -1 | -0.1% | 122,000 |
| 2011/12/08 | 1,344 | 1,366 | 1,340 | 1,350 | +8 | +0.6% | 190,000 |
3251～
3300
件表示中 / 3714件
類似銘柄と比較する
現在ご覧いただいている「杏林製薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 杏林製薬 | 148,500円 | -2.4% | -52.3% | 3.84% | 17.78倍 | 0.63倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| ゼリア新薬 | 204,600円 | +3.1% | -6.5% | 2.35% | 9.49倍 | 1.01倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| 持田薬 | 297,100円 | +5.1% | -7.0% | 2.69% | 19.51倍 | 0.80倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| ネクセラファーマ | 93,300円 | +20.3% | - | 0.00% | 165.43倍 | 1.23倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| 栄研化 | 200,900円 | +4.1% | -3.1% | 2.89% | 17.49倍 | 1.53倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム
